Increased brain histamine levels in Parkinson's disease but not in multiple system atrophy

Juha O. Rinne, Oleg Anichtchik, Kent Eriksson, Jan Kaslin, Leena Tuomisto, Hannu Kalimo, Matias Röyttä, Pertti Panula

Journal of Neurochemistry · 2002 · 165 citations · 33 references

Concepts

TL;DR

Regions such as the putamen, substantia nigra pars compacta, and globus pallidus are key to motor control and exhibit functional changes in Parkinson’s disease. The study aimed to compare histamine concentrations in post‑mortem brain tissue from Parkinson’s disease, multiple system atrophy patients, and age‑matched controls. Histamine levels were measured in the putamen, substantia nigra pars compacta, internal and external globus pallidus of 24 PD, 8 MSA, and 27 control brains. PD brains showed markedly elevated histamine in all examined regions (up to 234% of controls), whereas.

Abstract

Abstract We investigated histamine concentration in post‐mortem brain samples of patients with Parkinson's disease (PD, n = 24), multiple system atrophy (MSA, n = 8) and age‐matched controls ( n = 27). Histamine concentrations were significantly increased in the putamen (to 159% of the control mean), substantia nigra pars compacta (to 201%), internal globus pallidus (to 234%) and external globus pallidus (to 200%), i.e. in areas which play a crucial role in the motor behaviour and which show typical functional alterations in PD. In MSA no significant differences were seen. Tele‐methylhistamine (histamine metabolite) concentrations were unchanged in PD. These results indicate that histamine concentration, but not its metabolism is increased in PD, but not in MSA. This finding may have implications in developing new drug therapies for PD and in differential diagnosis between PD and MSA.

References

33